Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia

被引：0
|
作者：
B.T. Yilmaz
B. Alioglu
E. Ozyurek
H.T. Akay
S. Mercan
N. Ozbek
机构：
[1] Baskent University Faculty of Medicine,Department of Pediatrics, Pediatric Hematology Unit
[2] Baskent University Faculty of Medicine,Department of Cardiovascular Surgery
来源：
Pediatric Cardiology | 2005年 / 26卷
关键词：
Recombinant factor VIIa; Cardiopulmonary bypass; Cardiac surgery; Glanzmann thrombasthenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.
引用
收藏
页码：843 / 845
页数：2
相关论文
共 50 条
  • [31] Bleeding prophylaxis with recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing elective circumcision
    Pasia, SJ
    Valentino, LA
    PEDIATRIC RESEARCH, 2003, 53 (04) : 298A - 298A
  • [32] Adjunct use of NovoSeven (recombinant factor VIIa) for penetrating cardiac trauma
    Manuel Garcia-Nunez, Luis
    Enrique Soto-Ortega, Luis
    Cabello-Pasini, Ruy
    Enrique Payro-Hernandez, Luis
    Javier Magana-Sanchez, Ignacio
    CIRUGIA Y CIRUJANOS, 2008, 76 (01): : 95 - 98
  • [33] Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait
    Kanyike, FB
    Abdul-Salam, SA
    Prakash, B
    Sharhan, A
    Wahib, N
    Youssef, AH
    HAEMOPHILIA, 1999, 5 (04) : 273 - 275
  • [34] Recombinant Factor VIIa in Pediatric Cardiac Surgery
    Morrison, Shannon
    Lacey, Cara
    Attard, Chantal
    Davies, Ben
    Monagle, Paul
    Davies, Paul
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (03) : 684 - 689
  • [35] Successful in vitro fertilization (IVF) and pregnancy in Glanzmann's thrombasthenia under cover of recombinant factor VIIa
    Staritz, P.
    Zimmermann, R.
    Domschke, C.
    Strowitzki, T.
    Schuetz, F.
    Sohn, C.
    Huth-Kuehne, A.
    HAEMOPHILIA, 2012, 18 : 206 - 206
  • [36] Glanzmann thrombasthenia successfully operated for nasal deformation with recombinant factor VIIA
    Bay, Ali
    Oener, Ahmet Faik
    INDIAN PEDIATRICS, 2006, 43 (12) : 1094 - 1094
  • [37] Successful use of recombinant activated factor VII (eptacog alfa, Novoseven®) in a refractory bleeding during pediatric cardiac surgery: a case report
    Mariko Ishihara
    Yoshikazu Miyamoto
    Akihiro Taniguchi
    Keiko Kinouchi
    JA Clinical Reports, 1 (1)
  • [38] Confirmation of high dose recombinant factor VIIa in treating patients with Glanzmann thrombasthenia
    Chuansumrit, A
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (02) : 396 - 396
  • [39] The use of recombinant factor VIIa (NovoSeven®) in a patient with a factor XI deficiency and a circulating anticoagulant
    Billon, S
    Le Niger, C
    Escoffre-Barbe, M
    Vicariot, M
    Abgrall, JF
    BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (07) : 551 - 553
  • [40] Intensive Menstrual Bleeding Successfully Treated With Recombinant Factor VIIa in Glanzmann Thrombasthenia
    Balci, Yasemin Isik
    Karabulut, Aysun
    Kabukcu, Sibel
    Sari, Ismail
    Keskin, Ali
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (04) : 320 - 322
12345